These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21525007)

  • 1. Ras/mitogen-activated protein kinase (MAPK) signaling modulates protein stability and cell surface expression of scavenger receptor SR-BI.
    Wood P; Mulay V; Darabi M; Chan KC; Heeren J; Pol A; Lambert G; Rye KA; Enrich C; Grewal T
    J Biol Chem; 2011 Jul; 286(26):23077-92. PubMed ID: 21525007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mitogen-activated protein kinase Erk1/2 promotes protein degradation of ATP binding cassette transporters A1 and G1 in CHO and HuH7 cells.
    Mulay V; Wood P; Manetsch M; Darabi M; Cairns R; Hoque M; Chan KC; Reverter M; Alvarez-Guaita A; Rye KA; Rentero C; Heeren J; Enrich C; Grewal T
    PLoS One; 2013; 8(4):e62667. PubMed ID: 23634230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEK1 inhibits cardiac PPARα activity by direct interaction and prevents its nuclear localization.
    el Azzouzi H; Leptidis S; Bourajjaj M; van Bilsen M; da Costa Martins PA; De Windt LJ
    PLoS One; 2012; 7(6):e36799. PubMed ID: 22723831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer.
    Yeh JJ; Routh ED; Rubinas T; Peacock J; Martin TD; Shen XJ; Sandler RS; Kim HJ; Keku TO; Der CJ
    Mol Cancer Ther; 2009 Apr; 8(4):834-43. PubMed ID: 19372556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
    Lee SY; Shin SJ; Kim HS
    Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GABA
    Olianas MC; Dedoni S; Onali P
    Eur J Pharmacol; 2017 Jan; 794():135-146. PubMed ID: 27876620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of MAPK signaling on 1,25-dihydroxyvitamin D-mediated CYP24 gene expression in the enterocyte-like cell line, Caco-2.
    Cui M; Zhao Y; Hance KW; Shao A; Wood RJ; Fleet JC
    J Cell Physiol; 2009 Apr; 219(1):132-42. PubMed ID: 19097033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel changes in NF-{kappa}B activity during progression and regression phases of hyperplasia: role of MEK, ERK, and p38.
    Chandrakesan P; Ahmed I; Anwar T; Wang Y; Sarkar S; Singh P; Peleg S; Umar S
    J Biol Chem; 2010 Oct; 285(43):33485-33498. PubMed ID: 20710027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an emerging threat to anticancer therapy.
    Mandal R; Becker S; Strebhardt K
    Oncogene; 2016 May; 35(20):2547-61. PubMed ID: 26364606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly.
    Tsai J; Qiu W; Kohen-Avramoglu R; Adeli K
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):211-8. PubMed ID: 17038630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src tyrosine kinase inhibits apoptosis through the Erk1/2- dependent degradation of the death accelerator Bik.
    Lopez J; Hesling C; Prudent J; Popgeorgiev N; Gadet R; Mikaelian I; Rimokh R; Gillet G; Gonzalo P
    Cell Death Differ; 2012 Sep; 19(9):1459-69. PubMed ID: 22388352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEK-ERK (Raf/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase) pathway.
    Kim EJ; Juhnn YS
    J Biol Chem; 2015 Apr; 290(15):9604-13. PubMed ID: 25713071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor α positively regulates complement C3 expression but inhibits tumor necrosis factor α-mediated activation of C3 gene in mammalian hepatic-derived cells.
    Mogilenko DA; Kudriavtsev IV; Shavva VS; Dizhe EB; Vilenskaya EG; Efremov AM; Perevozchikov AP; Orlov SV
    J Biol Chem; 2013 Jan; 288(3):1726-38. PubMed ID: 23168409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Humanized IgG1 Antibody Promotes Reverse Cholesterol Transport through FcRn-ERK1/2-PPARα Pathway in Hepatocytes.
    Li Z; Zhang Q; Liu X; Zhao M
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERK1/2 can feedback-regulate cellular MEK1/2 levels.
    Hong SK; Wu PK; Karkhanis M; Park JI
    Cell Signal; 2015 Oct; 27(10):1939-48. PubMed ID: 26163823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor-2 promotes catabolism via FGFR1-Ras-Raf-MEK1/2-ERK1/2 axis that coordinates with the PKCδ pathway in human articular chondrocytes.
    Yan D; Chen D; Im HJ
    J Cell Biochem; 2012 Sep; 113(9):2856-65. PubMed ID: 22488450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products.
    Ohgami N; Nagai R; Miyazaki A; Ikemoto M; Arai H; Horiuchi S; Nakayama H
    J Biol Chem; 2001 Apr; 276(16):13348-55. PubMed ID: 11278947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sef downregulation by Ras causes MEK1/2 to become aberrantly nuclear localized leading to polyploidy and neoplastic transformation.
    Duhamel S; Hébert J; Gaboury L; Bouchard A; Simon R; Sauter G; Basik M; Meloche S
    Cancer Res; 2012 Feb; 72(3):626-35. PubMed ID: 22298595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High density lipoprotein-induced signaling of the MAPK pathway involves scavenger receptor type BI-mediated activation of Ras.
    Grewal T; de Diego I; Kirchhoff MF; Tebar F; Heeren J; Rinninger F; Enrich C
    J Biol Chem; 2003 May; 278(19):16478-81. PubMed ID: 12637559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of H-Ras and MAPK is compensated by PKC-dependent pathways in annexin A6 expressing cells.
    Rentero C; Evans R; Wood P; Tebar F; Vilà de Muga S; Cubells L; de Diego I; Hayes TE; Hughes WE; Pol A; Rye KA; Enrich C; Grewal T
    Cell Signal; 2006 Jul; 18(7):1006-16. PubMed ID: 16183252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.